dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Strategic Advisory Group of Experts

Sotsiaalministeerium · 4. september 2018
Viit
1.4-2/2827-1
Registreeritud
4. september 2018
Dokumendi liik
Sissetulev kiri
Adressaat
World Health Organization
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2018
Vastutaja
Madis Tõns (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Ravimiosakond)
Lahendamise tähtaeg
4. oktoober 2018

Failid

  • 📎C.L.29.2018 (SAGE IVD) (002).pdf97 KB
  • 📎E-kiri.pdf104 KB

Sisu (failidest)

20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT Ref.: C.L.29.2018 The World Health Organization (WHO) presents its compliments to Member States and Associate Members and invites them to nominate experts on in vitro diagnostics to be a candidate for membership to the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD). Since 2017, WHO constitutes and maintains a roster of experts to select each year’s SAGE IVD, an advisory body to WHO on matters of global policies and strategies related to IVDs. Its role includes to provide technical advice on global policies and strategies, ranging from development, assessment, use of IVDs and their linkages with other health interventions; suggest guiding principles for how, when and where to use particular IVDs in national, regional and global settings; review the pipeline of existing and innovative IVDs for noncommunicable diseases, rare diseases and infectious diseases, including for emerging pathogens and existing public health conditions of international concern, and identify major gaps; and provide advice to WHO Secretariat for the development of the WHO List of Essential Diagnostics (EDL). It is requested that the candidate has expertise in one or more of the following settings: • Ministry of health, (policy-making on IVD or medical devices); • national reference laboratory or laboratories in national teaching public hospitals; • assessment, validation, clinical trials, regulatory body; • selection, procurement and supply of IVDs; • pricing/reimbursement for IVDs. To be considered, candidates must be proficient in English and be able to demonstrate that they have the expertise, skills and experience to meet the criteria described below: • an understanding of the IVD issues covered by the Strategic Advisory Group (SAGE IVD); • an outstanding record of achievement and personal credibility within own field, appropriate to the remit of SAGE IVD; • experience in international settings; resource-limited settings; operating at a strategic level in the public or other sectors and/or working effectively in high level advisory groups or committees. Nominated candidates should submit their CV, motivation letter and a signed Declaration of Interest to: [email protected]. Page 2 C.L.29.2018 More detailed information on SAGE IVD and formats are available at the following link: http://www.who.int/medicines/news/2017/strategic_advisory_group_experts_in_vitro_iagnostics /en/. On related information: The first edition of the WHO Model List of Essential Diagnostics (EDL) was published on the WHO website in May 2018 (http://www.who.int/medical_devices/diagnostics/WHO_EDL_2018.pdf). It is foreseen that every year new tests and new information will be added, regarding neglected tropical diseases, health emergencies and outbreaks, antimicrobial resistance and other noncommunicable diseases. More information is available on: http://www.who.int/medical_devices/diagnostics/WHO_Essential_Diagnostics_List_2019_appli cation/ The next meeting of the SAGE IVD is planned to take place in WHO headquarters from 18 to 22 March 2019 and will include one open day for Member States’ participation. More information on the EDL, SAGE IVD and updates of the list, are available at: http://www.who.int/medical_devices/diagnostics/Selection_in-vitro_diagnostics/en/. Questions can be addressed by email to [email protected]. The World Health Organization takes this opportunity to renew to Member States and Associate Members the assurance of its highest consideration. GENEVA, 3 September 2018 Dear Member States of the World Health Organization, Please find attached, in the six official languages, C.L.29.2018. Best regards, Department for Governing Bodies World Health Organization
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel